Because BC is a heterogeneous disease that is caused by DNA mutations or epigenetic changes, we conjectured that these phenomena could disrupt the connection between SGSM2 and other genes in breast tumours, especially the ERBB2 gene. This evidence concerns the gene SGSM2 and breast cancer.